CRVS · Corvus Pharmaceuticals, Inc.
$14.10
-0.80 (-5.37%)
At close · Jul 20
Market Cap
$1.19B
Shares
84.09M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 12,844 | $14.48 | $185,981 |
| 2026-06-23 | 2,679 | $12.56 | $33,648 |
| 2026-06-16 | 1,504 | $11.90 | $17,898 |
| 2026-06-15 | 1,000 | $11.93 | $11,930 |
| 2026-06-12 | 2,932 | $11.60 | $34,011 |
| 2026-06-03 | 700 | $11.69 | $8,183 |
| 2026-06-02 | 732 | $12.08 | $8,843 |
| 2026-05-19 | 6,745 | $12.21 | $82,356 |
| 2026-05-13 | 2,653 | $15.97 | $42,368 |
| 2026-05-05 | 389 | $16.02 | $6,232 |
| 2026-04-27 | 224 | $16.08 | $3,602 |
| 2026-04-24 | 24 | $16.02 | $384 |
| 2026-04-23 | 58 | $17.85 | $1,035 |
| 2026-04-22 | 2,280 | $17.14 | $39,079 |
Showing 1–14 of 14 settlements
Key facts
CIK
1626971
CUSIP
221015100
13F (30d)
10 filings
10 filers
Visit website
Investor relations